As of 2025-07-12, the Relative Valuation of Aptose Biosciences Inc (APS.TO) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 2.50 CAD, the upside of Aptose Biosciences Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-07-10 | -0.04 |
| 2025-07-09 | -0.04 |
| 2025-07-08 | -0.04 |
| 2025-07-07 | -0.03 |
| 2025-07-04 | -0.02 |
| 2025-07-03 | -0.02 |
| 2025-07-02 | -0.02 |
| 2025-06-30 | -0.02 |
| 2025-06-27 | -0.02 |
| 2025-06-26 | -0.02 |
| 2025-06-25 | -0.02 |
| 2025-06-24 | -0.02 |
| 2025-06-23 | -0.02 |
| 2025-06-20 | -0.03 |
| 2025-06-19 | -0.02 |
| 2025-06-18 | -0.02 |
| 2025-06-17 | -0.03 |
| 2025-06-13 | -0.05 |
| 2025-06-12 | -0.05 |
| 2025-06-11 | -0.05 |
| 2025-06-10 | -0.05 |
| 2025-06-09 | -0.05 |
| 2025-06-06 | -0.05 |
| 2025-06-05 | -0.04 |
| 2025-06-04 | -0.05 |
| 2025-06-03 | -0.05 |
| 2025-06-02 | -0.05 |
| 2025-05-30 | -0.05 |
| 2025-05-29 | -0.05 |
| 2025-05-28 | -0.05 |
| 2025-05-27 | -0.05 |
| 2025-05-26 | -0.05 |
| 2025-05-23 | -0.05 |
| 2025-05-22 | -0.05 |
| 2025-05-21 | -0.05 |
| 2025-05-20 | -0.05 |
| 2025-05-16 | -0.05 |
| 2025-05-15 | -0.05 |
| 2025-05-14 | -0.05 |
| 2025-05-13 | -0.05 |
| 2025-05-12 | -0.04 |
| 2025-05-09 | -0.04 |
| 2025-05-08 | -0.04 |
| 2025-05-07 | -0.04 |
| 2025-05-06 | -0.05 |
| 2025-05-05 | -0.05 |
| 2025-05-02 | -0.05 |
| 2025-04-30 | -0.05 |
| 2025-04-29 | -0.06 |
| 2025-04-28 | -0.06 |